Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-22-000074
Filing Date
2022-02-14
Accepted
2022-02-14 18:19:16
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 33053
  Complete submission text file 0000874015-22-000074.txt   34504
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19125 | Film No.: 22635726